Editor’s Letter

Fourth and final issue of GaBI Journal’s fifth volume

Published in: Volume 5 / Year 2016 / Issue 4
Author(s):
Page: 147-8

This fourth and final GaBI Journal issue of 2016 begins with the paper by Adjunct Professor Pekka Kurki about ‘applying ancient principles in a modern society’ in which he discusses… Read More »

Latest features in GaBI Journal, 2016, Issue 3

Published in: Volume 5 / Year 2016 / Issue 3
Author(s):
Page: 99-100

The informed, appropriate use of follow-on pharmacological agents can provide significant cost savings for patients and payers. These savings can then be used by governments and patients to increase access… Read More »

What to look forward to in GaBI Journal, 2016, Issue 2

Published in: Volume 5 / Year 2016 / Issue 2
Author(s):
Page: 51-2

This second issue of 2016 includes manuscripts that cover a number of important issues of interest to GaBI Journal including methods used to assess bioequivalence and decide on interchangeability, patient and… Read More »

Editor’s introduction to the initial issue of the fifth volume of GaBI Journal

Published in: Volume 5 / Year 2016 / Issue 1
Author(s):
Page: 3

This issue begins with a Letter to the Editor by Professor Fabio V Teixeira from the Brazilian Inflammatory Bowel Disease (IBD) Society that deals basically with the issue of extrapolation… Read More »

Fourth and final issue of GaBI Journal’s fourth volume

Published in: Volume 4 / Year 2015 / Issue 4
Author(s):
Page: 157-8

This last issue of 2015 starts with a Commentary by Drs Christoph Baumgärtel and Brian Godman concerning the approval of generic versions of narrow therapeutic margin products; including immunosuppressant drugs.… Read More »

Latest features in GaBI Journal, 2015, Issue 3

Published in: Volume 4 / Year 2015 / Issue 3
Author(s):
Page: 105-6

This issue of the journal contains a number of manuscripts that discuss proposals to simplify the evaluation of, and therefore decrease the cost of developing, follow-on biological products. These controversial… Read More »

What to look forward to in GaBI Journal, 2015, Issue 2

Published in: Volume 4 / Year 2015 / Issue 2
Author(s):
Page: 57

This entire issue of the GaBI Journal could be titled ‘World News’ since it contains manuscripts describing global generics and biosimilar activities. The Commentary by Leng et al. describes regulatory… Read More »

Editor’s introduction to the initial issue of the fourth volume of GaBI Journal

Published in: Volume 4 / Year 2015 / Issue 1
Author(s):
Page: 5, 7

This first 2015 GaBI Journal issue (fourth volume of the journal) is being published soon after the first US biosimilar approval and it contains a number of articles that illustrate… Read More »

Fourth and final issue of GaBI Journal’s third volume

Published in: Volume 3 / Year 2014 / Issue 4
Author(s):
Page: 161

The interest in the development, regulatory approval, use, and post-marketing surveillance of generic and biosimilar pharmaceutical products continues to increase; as illustrated by the tremendous number of views (over 1,028,324… Read More »

Latest features in GaBI Journal, 2014, Issue 3

Published in: Volume 3 / Year 2014 / Issue 3
Author(s):
Page: 105

This issue of the GaBI Journal begins with editorial comments from our Deputy Editor-in-Chief Dr Robin Thorpe concerning the Review Article by Azevedo et al. covering biosimilar regulations and their… Read More »

Page 3 of 4 « Previous1 2 3 4 Next »
Go Back Print